Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Obstetrics
New research in the area of obstetrics detailed
December 8th, 2005
Investigators in the United States, Israel and United Kingdom have published new obstetrics data. Study 1: The uterus may produce excess vascular endothelial growth factor (VEGF) receptor in preeclamptic women. "Preeclampsia has been considered an antiangiogenic state. Two factors have been implicated in the genesis of this state: soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) and placental growth factor (PlGF)," scientists in the United States report. "Indeed, the concentrations of PlGF, an angiogenic factor, are lower in preeclampsia than in normal pregnancy, while the opposite is the case for the...
Source: Women's Health Weekly (2005-12-08)
|
